Meta-analysis compares DAPT and thrombolysis efficacy for minor stroke, indicating important treatment options.
Objective Minor ischemic stroke (NIHSS ≤ 5) presents a therapeutic dilemma, balancing the potential benefits of intravenous thrombolysis (IVT) against its hemorrhagic risks, with dual antiplatelet therapy (DAPT) established for recurrence prevention. This meta-analysis compares the efficacy and safety of dual antiplatelet therapy (DAPT) versus intravenous thrombolysis (IVT) in patients with minor stroke, examining functional recovery, the risk of symptomatic intracranial haemorrhage (SICH) and mortality.
No takes yet. Share an insight, caveat, or question.
Shoaib et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: